Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis

Journal of Hepatology

Volumn 28, Issue 1, 1998, Pages 115-121

  Caregaro, Lorenza ^a   Alberino, Franca ^a   Amodio, Piero ^a   Merkel, Carlo ^a   Angeli, Paolo ^a   Plebani, Mario ^a   Gatta, Angelo ^a  

^a NONE

Author keywords

Liver cirrhosis; Nutrition; Survival; Thyroid hormone

Indexed keywords

LIOTHYRONINE; MUSCLE PROTEIN; PLASMA PROTEIN; THYROXINE;

ADULT; ARTICLE; EUTHYROID SICK SYNDROME; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUTRITIONAL DEFICIENCY; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; THYROID HORMONE METABOLISM; THYROXINE BLOOD LEVEL;

EID: 0031889550     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80210-9     Document Type: Article

References (38)

1. Chopra IJ, Hershman JM, Pardrige WM, Nicoloff JT. Thyroid function in nonthyroidal illness. Ann Intern Med. 98:1983;946-957.
2. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttal FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 245:1981;43-45.
3. McLarty DG, Ratcliffe WA, McColl K, Stone D, Ratcliffe JG. Thyroid hormone levels and prognosis in patients with severe nonthyroidal illness. Lancet. 2:1975;275-276.
4. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thryoid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol. 16:1982;565-574.
5. Silberman H, Eisenberg D, Ryan J, Shofler R, Niland J, Kaptein E, et al. The relation of thyroid indices in the critically ill patient to prognosis and nutritional factors. Surg Gynecol Obstet. 166:1988;223-228.
6. Vagenakis AG, Burger A, Portnay GI, Rudolph M, O'Brian JT, Azizi F, et al. Diversion of peripheral thyroixine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab. 41:1975;191-194.
7. 3 in man. J Clin Endocrinol Metab. 42:1976;197-200.
8. Chopra IJ, Smith SR. Circulating thyroid hormones and thyrotropin in adult patients with protein-calorie malnutrition. J Clin Endocrinol Metab. 40:1975;221-227.
9. Eisenberg D, Silberman H, Ryan J, Shofler R, Weiss J, Kaptein E, et al. Prognostic significance of thyroid function tests in critically ill patients. Surg Forum. 31:1980;211-213.
10. Mendenhall CL, Anderson S, Weesner RE. Protein-calorie malnutrition associated with alcoholic hepatitis. Am J Med. 76:1984;211-222.
11. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 63:1996;602-609.
12. Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. Nutritional status in cirrhosis J Hepatol. 21:1994;317-325.
13. Thuluvat PJ, Triger DR. Evaluation of nutritional status by using anthropometry in adults with alcoholic and nonalcoholic liver disease. Am J Clin Nutr. 60:1994;269-273.
14. Green JRB, Snitcher EJ, Mowat NAG, Ekins RP, Rees LH, Dawson AM. Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities. Clin Endocrinol. 7:1977;453-461.
15. Israel Y, Walfish PG, Orrego H, Blake J, Kalant H. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil. Gastroenterology. 76:1979;116-122.
16. Borzio M, Caldara R, Borzio F, Piepoli V, Rampini P, Ferrari C. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut. 24:1983;631-636.
17. 3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction. Gastroenterology. 78:1983;750-755.
18. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
19. Plebani M, Perobelli L, Burlina A. New method ("SPAC ET") for free thyroxin in serm evaluated. Clin Chem. 32:1986;680-683.
20. Frisancho AR. New norms of upper limb fat and muscle area for assessment of nutritional status. Am J Clin Nutr. 34:1981;2540-2545.
21. Merli M, Romiti A, Riggio O, Capocaccia L. Optimal nutritional indexes in chronic liver disease. JPEN. 11:1987;130-134.
22. Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition. 13:1997;185-190.
23. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 7:1987;660-664.
24. Conn HO. A peek at the Child-Turcotte classification. Hepatology. 1:1981;673-676.
25. Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T, et al. VA Cooperative Study on Alcoholic Hepatitis II: prognostic significance of protein-calorie malnutrition. Am J Clin Nutr. 43:1986;213-218.
26. Abad-Lacruz A, Cabré E, Gonzalez-Huix F, Fernandez Banãres F, Esteve M, Planas R, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleedings advanced cirrhotics. Am J Gastroenterol. 88:1993;382-387.
27. McConnon J, Row VW, Volpe R. The influence of liver damage in man on the distribution and disposal rates of thyroxine and triiodothyronine. Clin Endocrinol. 34:1972;144-151.
28. Nomura S, Pittman CS, Chamber JB Jr, Buck MW, Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest. 56:1975;643-652.
29. 3. J Clin Endocrinol Metab. 56:1983;1152-1163.
30. 3 and thyroid hormone binding inhibitor in patients with various nonthyroidal illness. Endocrinol Jpn. 39:1992;445-453.
31. Chopra IJ, Teco GN, Mead JF, Hung T-S, Beredo A, Solomon DH. Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroidal illnesses. J Clin Endocrinol Metab. 60:1985;980-984.
32. Van Noorden CJF, Wiersinga WM, Touber JL. Propanolol inhibits the in vitro conversion of thyroxine to triiodothyronine by isolated rat liver parenchymal cells. Horm Metab Res. 11:1979;366-372.
33. Chopra IJ, Solomon DH, Chua-Teco GN, Nguyen AH. Inhibition of hepatic outer ring monodiiodinations of thyroxine and 3,3′,5′-triiodothyronine by sodium salicylate. Endocrinology. 106:1980;1728-1734.
34. 3 levels in hepatic cirrhosis: role of glucagon. Am J Gastroenterol. 86:1991;1504-1507.
35. Müller MJ, Böker KHW, Selberg O. Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin Invest. 72:1994;568-579.
36. Müller MJ, Lautz HU, Plogmann B, Bürger M, Körber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional status. Hepatology. 15:1992;782-794.
37. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, et al. Basal energy production rate and substrate use in stable patients with cirrhosis. Hepatology. 12:1990;106-112.
38. McCollough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis. 11:1991;265-277.